Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 77.59K 72.56K 66.12K 124K 8.41M 126K 878K 340K 4.28M 328K 321K 13.76M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 218M 204M 186M 350M 23.66B 355M 2.47B 956M 12.05B 923M 903M 38.7B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.62%-2.71%+39.30%+114.07% 1,025B
-2.30%-4.44%+39.03%+66.07% 623B
-0.63%-1.96%+6.36%+74.38% 459B
-1.03%-2.82%+59.56%+39.69% 355B
-0.03%-3.96%+23.63%+39.35% 336B
-1.58%-0.76%+13.50%+25.77% 270B
-2.02%-2.97%-3.25%+8.38% 247B
-3.38%+0.30%+36.44%+51.54% 220B
-1.04%-1.46%+32.70%+96.82% 183B
Average -1.26%-1.70%+27.47%+57.34% 371.82B
Weighted average by Cap. -1.24%-2.11%+30.51%+69.30%

Financials

2016 2017
Net sales 54.27M 48.2M 45.08M 41.08M 77.34M 5.23B 78.4M 545M 211M 2.66B 204M 199M 8.55B 106M 94.1M 88M 80.19M 151M 10.2B 153M 1.06B 412M 5.2B 398M 389M 16.69B
Net income -103M -91.47M -85.54M -77.95M -147M -9.91B -149M -1.03B -401M -5.05B -387M -378M -16.22B -125M -111M -104M -94.77M -178M -12.05B -181M -1.26B -487M -6.14B -470M -460M -19.72B
Net Debt 209M 186M 174M 159M 299M 20.17B 303M 2.11B 815M 10.27B 787M 770M 32.99B 246M 218M 204M 186M 350M 23.65B 355M 2.47B 956M 12.05B 922M 902M 38.69B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock